Surprise discovery shows multiple sclerosis sufferers' lives are significantly improved by taking statins

 

Health Reporter

People living with late-stage multiple sclerosis (MS) could have their condition significantly improved by taking statins, doctors have found, in a “surprise” discovery which could be of major benefit to thousands of sufferers.

In results described as “very exciting” by the leading MS charity, researchers found that taking a large daily dose of statins, which are commonly used to reduce the risk of heart disease, could also slow the progression of MS in its later, more debilitating phase.

Patients who took the drugs over two years experienced less severe symptoms of disability, and magnetic resonance imaging (MRI) scans revealed that their brains shrank at a slower rate than patients who took a placebo.

MS, a disease of the brain and nervous system which causes problems with movement, balance and vision, affects around 100,000 people in the UK. While it can be managed in its early phase, when patients often experience days, weeks or even months without symptoms, most sufferers go on to develop secondary progressive MS within 15 years of diagnosis, which is more severe and largely untreatable.

While the disease is not fatal, there is no cure and it can lead to people becoming severely disabled and vulnerable to complications. The average life expectancy of people with MS is around 10 years lower than the population at large. Women are three times more likely to have the disease as men.

The study, published in The Lancet medical journal today which was conducted at Imperial College London, is the culmination of many years of research in collaboration with University College London (UCL), into the potential benefits of statins as a treatment for autoimmune diseases.

Dr Richard Nicholas, of Imperial’s Faculty of Medicine, who coauthored the paper with Dr Jeremy Chataway, said that their findings were particularly promising, as statins are already cheap and widely used, and could, in theory, be rolled out as an MS treatment quickly and with widespread impact.

“At the moment, we don’t have anything that can stop patients from becoming more disabled once MS reaches the progressive phase,” he said. “Discovering that statins can help slow that deterioration is quite a surprise.”

In late stage MS the brain shrinks by around 0.6 per cent per year, said Dr Chataway, who is now at UCL. In patients who received statins, that shrinkage was reduced to 0.3 per cent a year – a 43 per cent reduction compared to the placebo group.

Dr Chataway urged caution on the brain imaging findings, which he said would did not necessarily translate to clinical benefit, but agreed that the findings were “promising”.

Patients on statins also scored better on tests of disability: both self-reported, and in assessments by doctors.

Large phase-three clinical trials were now required to confirm the findings of the study, which only looked at 140 MS patients, the researchers said.

“Scientists have worked for years to find a potential treatment that could help people, and now, finally, one has been found,” said Dr Susan Kohlhaas, head of biomedical research at the MS Society. “This is very exciting news.”

Professor John Greenwood, of UCL’s Institute of Ophthalmology, who has led research efforts into statins said: “After nearly two decades of research, it is immensely gratifying to see this work progress into the clinic to deliver benefits to patients.”

Life and Style
ebookNow available in paperback
Latest stories from i100
Have you tried new the Independent Digital Edition apps?

ES Rentals

    Independent Dating
    and  

    By clicking 'Search' you
    are agreeing to our
    Terms of Use.

    iJobs Job Widget
    iJobs General

    Guru Careers: Software Developer / C# Developer

    £40-50K: Guru Careers: We are seeking an experienced Software / C# Developer w...

    Guru Careers: Software Developer

    £35 - 40k + Benefits: Guru Careers: We are seeking a Software Developer (JavaS...

    SThree: Trainee Recruitment Consultant / Resourcer

    £18000 - £23000 per annum + Commission: SThree: As a Trainee Recruitment Consu...

    Ashdown Group: UI Developer - (UI, HTML, CSS, JavaScript, AngularJS)

    £25000 - £40000 per annum: Ashdown Group: UI Developer - (UI, JavaScript, HTML...

    Day In a Page

    Sun, sex and an anthropological study: One British academic's summer of hell in Magaluf

    Sun, sex and an anthropological study

    One academic’s summer of hell in Magaluf
    From Shakespeare to Rising Damp... to Vicious

    Frances de la Tour's 50-year triumph

    'Rising Damp' brought De la Tour such recognition that she could be forgiven if she'd never been able to move on. But at 70, she continues to flourish - and to beguile
    'That Whitsun, I was late getting away...'

    Ian McMillan on the Whitsun Weddings

    This weekend is Whitsun, and while the festival may no longer resonate, Larkin's best-loved poem, lives on - along with the train journey at the heart of it
    Kathryn Williams explores the works and influences of Sylvia Plath in a new light

    Songs from the bell jar

    Kathryn Williams explores the works and influences of Sylvia Plath
    How one man's day in high heels showed him that Cannes must change its 'no flats' policy

    One man's day in high heels

    ...showed him that Cannes must change its 'flats' policy
    Is a quiet crusade to reform executive pay bearing fruit?

    Is a quiet crusade to reform executive pay bearing fruit?

    Dominic Rossi of Fidelity says his pressure on business to control rewards is working. But why aren’t other fund managers helping?
    The King David Hotel gives precious work to Palestinians - unless peace talks are on

    King David Hotel: Palestinians not included

    The King David is special to Jerusalem. Nick Kochan checked in and discovered it has some special arrangements, too
    More people moving from Australia to New Zealand than in the other direction for first time in 24 years

    End of the Aussie brain drain

    More people moving from Australia to New Zealand than in the other direction for first time in 24 years
    Meditation is touted as a cure for mental instability but can it actually be bad for you?

    Can meditation be bad for you?

    Researching a mass murder, Dr Miguel Farias discovered that, far from bringing inner peace, meditation can leave devotees in pieces
    Eurovision 2015: Australians will be cheering on their first-ever entrant this Saturday

    Australia's first-ever Eurovision entrant

    Australia, a nation of kitsch-worshippers, has always loved the Eurovision Song Contest. Maggie Alderson says it'll fit in fine
    Letterman's final Late Show: Laughter, but no tears, as David takes his bow after 33 years

    Laughter, but no tears, as Letterman takes his bow after 33 years

    Veteran talkshow host steps down to plaudits from four presidents
    Ivor Novello Awards 2015: Hozier wins with anti-Catholic song 'Take Me To Church' as John Whittingdale leads praise for Black Sabbath

    Hozier's 'blasphemous' song takes Novello award

    Singer joins Ed Sheeran and Clean Bandit in celebration of the best in British and Irish music
    Tequila gold rush: The spirit has gone from a cheap shot to a multi-billion pound product

    Join the tequila gold rush

    The spirit has gone from a cheap shot to a multi-billion pound product
    12 best statement wallpapers

    12 best statement wallpapers

    Make an impact and transform a room with a conversation-starting pattern
    Paul Scholes column: Does David De Gea really want to leave Manchester United to fight it out for the No 1 spot at Real Madrid?

    Paul Scholes column

    Does David De Gea really want to leave Manchester United to fight it out for the No 1 spot at Real Madrid?